bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Radiopharm Theranostics Limited logo

    Radiopharm Theranostics Limited

    RADX | NASDAQ
    Chart Builder DCF Calculator
    $1.61
    -$0.04 (-2.42%)
    At close: Sep 21, 2026, 4:00 PM ET
    $1.61
    $0 (0.00%)
    After-hours: Sep 21, 2026, 4:10 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $2.13M
    Enterprise Value
    $-1.14M
    Beta
    0.80
    Average Volume
    62.2K
    Shares Outstanding (Diluted)
    39.39K
    Shares Change YoY
    N/A
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US75041J1016

    Price Performance

    Price Change 1M
    -33.7%
    Price Change 3M
    -63.2%
    Price Change 6M
    -62.8%
    Price Change YTD
    -68.8%
    Price Change 1Y
    -73.4%
    Price Change 3Y
    -91.5%
    Price Change 5Y
    -91.5%
    1M CAGR (ann.)
    -40.9%
    1Y CAGR (ann.)
    -76.8%
    5Y CAGR (ann.)
    N/A
    All-Time CAGR
    -73.5%

    Valuation

    PE Ratio
    -0.00
    Forward PE
    N/A
    PEG Ratio
    -0.01
    Forward PEG
    0.12
    PS Ratio
    1.11
    Forward PS
    1.30
    PB Ratio
    0.12
    P/FCF Ratio
    -0.14
    P/Adj. FCF Ratio
    -0.14
    P/OCF Ratio
    -0.53
    EV/Sales
    -0.41
    EV/EBIT
    0.02
    EV/EBITDA
    0.02
    EV/FCF
    0.05
    Earnings Yield
    -62103.0%
    FCF Yield
    -764.2%
    Adj. FCF Yield
    -764.2%

    Financial Health

    Net Cash
    A$4.14M
    Total Debt
    A$0
    Cash & Short-Term Investments
    A$4.14M
    Total Assets
    A$60.14M
    Current Ratio
    1.16
    Quick Ratio
    1.16
    Debt / Equity Ratio
    0.00
    Debt / EBITDA
    -0.00
    Debt / FCF
    -0.00
    OCF / Debt
    N/A
    Interest Coverage
    -626.93
    Altman Z-Score
    -8.36
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    -39.4%
    Operating Profit Margin
    -2550.7%
    EBITDA Margin
    -2496.8%
    Net Profit Margin
    -1992.5%
    FCF Margin
    -805.8%
    Adj. FCF Margin
    -805.8%
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    N/A

    Returns

    Return on Assets
    -91.7%
    Return on Equity
    -144.2%
    Return on Invested Capital
    -158.1%
    Return on Capital Employed
    -170.9%
    Return on Tangible Assets
    -251.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    110.0%
    Revenue CAGR 5Y
    N/A
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    102.9%
    EPS CAGR 5Y
    N/A
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    57.8%
    FCF CAGR 5Y
    N/A
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    1
    EPS Growth Next 3Y
    33.3%
    Revenue Growth Next 3Y
    211.7%
    Earnings Date
    Feb 25, 2027
    EPS Estimate (next Q)
    -$0.75
    EPS Growth Est (next Q)
    -53.3%
    Revenue Est (next Q)
    $497.97K
    Revenue Growth Est (next Q)
    -29.2%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $6
    Price Target Upside
    272.7%

    Cash Flow

    Operating Cash Flow
    A$-54.34M
    Free Cash Flow
    A$-22.26M
    Adj. Free Cash Flow
    A$-22.26M
    FCF Per Share
    -$1.93
    OCF Per Share
    -$4.49
    OCF/S Ratio
    -1907.0%

    Income Statement

    Revenue
    A$2.76M
    Gross Profit
    A$-1.07M
    Operating Income
    A$-70.45M
    EBITDA
    A$-69.12M
    Net Income
    A$-55.05M
    EPS (Diluted)
    -$1,404
    Revenue / Employee
    $197.28K
    Profit / Employee
    $-3.93M
    Employees
    14

    © 2026 bestshares.com. All rights reserved.